Search Results 351-360 of 11730 for Drug-resistant TB
The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. A Study to Evaluate the QuantiFERON-TB ...
Tafamidis is used to treat cardiomyopathy (enlarged and thickened heart muscle) of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in ...
The purpose of this study, as a proof-of-concept, is to investigate whether ex vivo fluorescence microscopy can provide adequate visualization of cutaneous ...
Drug Interactions. Although certain medicines ... Tuberculosis, active—Use is not recommended in patients with these conditions. ... Also, the number of doses you ...
... treatment period followed by a 24-week observation period. The primary objective of this study is to assess the proportion of treatment-resistant subjects ...
In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of the coronary anatomy, data ...
Post Approval Study For Treatment Of Drug-resistant Adult Primary FSGS Using The LIPOSORBER® LA-15 System. Scottsdale/Phoenix, Ariz., Jacksonville, Fla ...
Zelalem Temesgen, M.D., studies infectious disease epidemiology, treatment and prevention, primarily focusing on HIV and tuberculosis. His research interests ...
Binimetinib belongs to the group of medicines, called antineoplastics (cancer medicines). This medicine is available only with your doctor's prescription. This ...
About this study. This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.